DermTech Historical Income Statement
| DMTK Stock | USD 0.60 0.01 1.69% |
Historical analysis of DermTech income statement accounts such as Selling General Administrative of 46 M or Total Revenue of 16.1 M can show how well DermTech performed in making a profits. Evaluating DermTech income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of DermTech's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining DermTech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DermTech is a good buy for the upcoming year.
DermTech |
About DermTech Income Statement Analysis
DermTech Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to DermTech shareholders. The income statement also shows DermTech investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
DermTech Income Statement Chart
DermTech Income Statement is one of the three primary financial statements used for reporting DermTech's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of DermTech revenue and expense. DermTech Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, DermTech's Cost Of Revenue is quite stable compared to the past year. Total Operating Expenses is expected to rise to about 109.2 M this year, although the value of EBIT is projected to rise to (98.6 M). Add Fundamental
Operating Income
Operating Income is the amount of profit realized from DermTech operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of DermTech is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from DermTech's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into DermTech current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DermTech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.At this time, DermTech's Cost Of Revenue is quite stable compared to the past year. Total Operating Expenses is expected to rise to about 109.2 M this year, although the value of EBIT is projected to rise to (98.6 M).
DermTech income statement Correlations
Click cells to compare fundamentals
DermTech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
DermTech income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 2.7M | 40K | 151K | 1.3M | 1.5M | 1.6M | |
| Selling General Administrative | 8.9M | 13.8M | 24.8M | 36.1M | 43.8M | 46.0M | |
| Total Revenue | 3.4M | 5.9M | 11.8M | 14.5M | 15.3M | 16.1M | |
| Gross Profit | 60K | (96K) | 1.3M | 647K | 276K | 289.8K | |
| Other Operating Expenses | 21.0M | 41.2M | 89.2M | 132.7M | 119.0M | 125.0M | |
| Operating Income | (17.6M) | (35.3M) | (77.4M) | (118.2M) | (103.7M) | (98.6M) | |
| Net Income From Continuing Ops | (19.7M) | (35.2M) | (78.3M) | (116.7M) | (100.9M) | (95.8M) | |
| Ebit | (17.6M) | (35.3M) | (77.4M) | (118.2M) | (103.7M) | (98.6M) | |
| Research Development | 2.5M | 5.3M | 16.3M | 24.1M | 15.2M | 8.6M | |
| Cost Of Revenue | 3.3M | 6.0M | 10.6M | 13.9M | 15.0M | 15.8M | |
| Total Operating Expenses | 17.7M | 35.2M | 78.7M | 118.8M | 104.0M | 109.2M | |
| Income Before Tax | (19.7M) | (35.2M) | (78.3M) | (116.7M) | (100.9M) | (95.8M) | |
| Total Other Income Expense Net | (2.1M) | 40K | (937K) | 1.5M | 2.9M | 3.0M | |
| Net Income Applicable To Common Shares | (19.7M) | (35.2M) | (78.3M) | (116.7M) | (105.0M) | (99.8M) | |
| Net Income | (21.9M) | (34.7M) | (77.0M) | (113.7M) | (100.9M) | (95.8M) | |
| Income Tax Expense | 2.2M | (526K) | (1.4M) | (3.0M) | (2.7M) | (2.5M) | |
| Ebitda | (18.0M) | (34.8M) | (76.3M) | (118.3M) | (97.9M) | (93.0M) | |
| Net Interest Income | (2.7M) | 40K | 151K | 1.3M | 2.8M | 3.0M | |
| Interest Income | 2.7M | 40K | 151K | 1.3M | 2.8M | 3.0M |
Pair Trading with DermTech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DermTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DermTech will appreciate offsetting losses from the drop in the long position's value.Moving against DermTech Stock
| 0.85 | HCWB | HCW Biologics | PairCorr |
| 0.84 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
| 0.82 | KRYS | Krystal Biotech Financial Report 13th of May 2024 | PairCorr |
| 0.75 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.56 | CGC | Canopy Growth Corp Financial Report 27th of June 2024 | PairCorr |
The ability to find closely correlated positions to DermTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DermTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DermTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DermTech to buy it.
The correlation of DermTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DermTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DermTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DermTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DermTech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy DermTech Stock please use our How to buy in DermTech Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for DermTech Stock analysis
When running DermTech's price analysis, check to measure DermTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DermTech is operating at the current time. Most of DermTech's value examination focuses on studying past and present price action to predict the probability of DermTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DermTech's price. Additionally, you may evaluate how the addition of DermTech to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is DermTech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DermTech. If investors know DermTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DermTech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.09) | Revenue Per Share 0.469 | Quarterly Revenue Growth 0.311 | Return On Assets (0.38) | Return On Equity (1.06) |
The market value of DermTech is measured differently than its book value, which is the value of DermTech that is recorded on the company's balance sheet. Investors also form their own opinion of DermTech's value that differs from its market value or its book value, called intrinsic value, which is DermTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DermTech's market value can be influenced by many factors that don't directly affect DermTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DermTech's value and its price as these two are different measures arrived at by different means. Investors typically determine if DermTech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DermTech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.